Cy5 SARS-CoV-2 Omicron Variant (B.1.1.529) Spike Glycoprotein mRNA

Cat #: EG-358

   

Qty   
Product Name Cyanine 5-UTP Modified SARS-CoV-2 Omicron Variant (B.1.1.529) Spike Glycoprotein mRNA
Features
  • 5' Cap: Capped with ARCA (Anti Reverse Cap Analog, m7(3'-O-methyl)-G(5')ppp(5')G, Cap 0) or CleanCap AG (m7G(5')ppp(5')(2'OMeA)pG, Cap 1)
  • Codon Optimization: Human
  • Fluorescent Nucleotide: Cyanine 5-UTP
  • Nucleotide Modifications: mRNA modified with both Pseudo-UTP and 5mCTP
  • PolyA: 180 nt
Application Animal Vaccine Research (Not for human use)
Concentration ~1 μg/μl
Transfection Protocol Lipofectamine™ MessengerMAX™ Transfection Reagent Protocol
QC Agarose gel electrophoresis
Shipping Dry ice
Storage -80 oC